Male Contraceptives Near Human Trials

Medicine

MSI PI Gunda Georg (Regents Professor; Director, Institute for Therapeutics Discovery and Development) has been interviewed by several media outlets about a new contraceptive pill for men that may soon enter clinical trials. The pill, which works by blocking sperm production, is 99% effective in mice and is completely reversable.

Stories about this research appear on the following websites:

MSI provides resources and user support to researchers at the Institute for Therapeutics Discovery and Development. Regents Professor Georg was inducted into the Americal Chemical Society's (ACS) Medicinal Chemistry Hall of Fame during the ACS meeting this month.

Archive